Amlodipine-Valsartan 5-320mg Tabs

Manufacturer MYLAN Active Ingredient Amlodipine and Valsartan(am LOE di peen & val SAR tan) Pronunciation am-LOE-di-peen & val-SAR-tan
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Calcium Channel Blocker (CCB) / Angiotensin II Receptor Blocker (ARB) Combination
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jun 2007
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs, amlodipine and valsartan, used to treat high blood pressure (hypertension). Amlodipine helps relax blood vessels, and valsartan blocks a natural substance in the body that narrows blood vessels. Together, they help lower blood pressure, which can reduce the risk of heart attack, stroke, and kidney problems.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, and it's best to take it at the same time every day. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

It's also important to drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To keep your medication safe and effective, store it at room temperature in a dry place, away from the bathroom. Keep all medications out of the reach of children and pets, and store them in a secure location. When you're finished with your medication or it's expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your doctor or pharmacist. If you're unsure about how to dispose of your medication, ask your pharmacist for guidance. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take medication exactly as prescribed, usually once daily, with or without food.
  • Do not stop taking the medication without consulting your doctor, even if you feel well.
  • Continue to follow a low-sodium, low-fat diet as recommended by your doctor.
  • Engage in regular physical activity (e.g., 30 minutes of moderate exercise most days of the week).
  • Limit alcohol intake.
  • Avoid smoking.
  • Monitor your blood pressure regularly at home as advised by your doctor.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial dose 5/160 mg or 5/320 mg orally once daily. May be titrated up to a maximum of 10/320 mg once daily.
Dose Range: 5 - 320 mg

Condition-Specific Dosing:

hypertension: Initial dose 5/160 mg or 5/320 mg orally once daily. May be titrated up to a maximum of 10/320 mg once daily based on blood pressure response and tolerability.
substitution_therapy: May substitute for the individually titrated components. Patients receiving valsartan and amlodipine from separate tablets may be switched to Amlodipine-Valsartan tablets containing the same component doses.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No initial dose adjustment required (CrCl â‰Ĩ30 mL/min).
Moderate: No initial dose adjustment required (CrCl â‰Ĩ30 mL/min).
Severe: Use with caution (CrCl <30 mL/min). Monitor potassium and renal function. Valsartan is not removed by hemodialysis.
Dialysis: Use with caution. Valsartan is not removed by hemodialysis. Amlodipine is not dialyzable.

Hepatic Impairment:

Mild: No initial dose adjustment for valsartan. For amlodipine, consider lower starting dose (e.g., 2.5 mg amlodipine component) if severe impairment.
Moderate: No initial dose adjustment for valsartan. For amlodipine, consider lower starting dose (e.g., 2.5 mg amlodipine component) if severe impairment.
Severe: Use with caution. For amlodipine, a lower starting dose (e.g., 2.5 mg amlodipine component) is recommended. Valsartan exposure is increased in patients with severe hepatic impairment, but no dose adjustment is recommended for mild to moderate impairment.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Amlodipine is a dihydropyridine calcium channel blocker (CCB) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. This leads to peripheral arterial vasodilation and reduction in peripheral vascular resistance, thereby lowering blood pressure. Valsartan is an angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This inhibition prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased sodium and water reabsorption, ultimately lowering blood pressure.
📊

Pharmacokinetics

Absorption:

Bioavailability: Amlodipine: 64-90%; Valsartan: 23%
Tmax: Amlodipine: 6-12 hours; Valsartan: 2-4 hours
FoodEffect: Amlodipine: Not significantly affected by food; Valsartan: Food decreases AUC by 48% and Cmax by 59%, but does not significantly affect clinical efficacy.

Distribution:

Vd: Amlodipine: 21 L/kg; Valsartan: 17 L
ProteinBinding: Amlodipine: ~97.5%; Valsartan: ~94-97%
CnssPenetration: Amlodipine: Limited; Valsartan: Limited

Elimination:

HalfLife: Amlodipine: 30-50 hours; Valsartan: 6 hours
Clearance: Not available for combination; Amlodipine: 7 mL/min/kg; Valsartan: 2 L/hr
ExcretionRoute: Amlodipine: Urine (60% as metabolites, 10% unchanged), Feces (10%); Valsartan: Feces (83% unchanged), Urine (13% unchanged)
Unchanged: Amlodipine: ~10% in urine; Valsartan: ~83% in feces, ~13% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Amlodipine: 24-48 hours (full effect); Valsartan: 2 hours
PeakEffect: Amlodipine: 6-12 hours; Valsartan: 2-4 hours
DurationOfAction: Amlodipine: 24 hours; Valsartan: 24 hours
Confidence: High

Safety & Warnings

âš ī¸

BLACK BOX WARNING

When pregnancy is detected, discontinue Amlodipine-Valsartan as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Severe dizziness or fainting
New or worsening chest pain
Swelling in the arms or legs
Stiff muscles, shakiness, or abnormal muscle movements

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or do not go away:

Dizziness
Nose or throat irritation
* Signs of a common cold

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting (especially when standing up)
  • Swelling of the face, lips, tongue, or throat (signs of angioedema)
  • Difficulty breathing or swallowing
  • Persistent or worsening swelling in the ankles or feet
  • Unusual muscle weakness or irregular heartbeat (signs of high potassium)
  • Signs of kidney problems (e.g., decreased urination, swelling in legs/feet, unusual tiredness)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have kidney disease, as this may affect how your body processes the medication.
If you are currently taking a medication that contains aliskiren, particularly if you have diabetes or kidney problems, as this combination may increase the risk of adverse effects.
If you are breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication in combination with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, be cautious when driving or performing tasks that require alertness, as it may affect you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position and exercise caution when navigating stairs.

Regularly monitor your blood pressure as directed by your healthcare provider. Additionally, adhere to the schedule for blood work and other laboratory tests as recommended by your doctor.

Be aware that this medication may rarely cause new or worsening chest pain, which can increase the risk of a heart attack. This risk may be higher in individuals with severe heart blood vessel disease. Discuss these potential risks with your doctor.

Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids, consult with your doctor.

If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, inform your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

It may take several weeks to experience the full effects of this medication. Before consuming alcohol, talk to your doctor.

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, notify your doctor, as these symptoms may lead to low blood pressure.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (very low blood pressure)
  • Bradycardia (slow heart rate)
  • Tachycardia (fast heart rate)
  • Peripheral vasodilation with reflex tachycardia
  • Shock
  • Electrolyte disturbances (e.g., hyperkalemia)

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management includes symptomatic and supportive care, including elevation of extremities, fluid administration, and vasopressors for hypotension. Calcium gluconate may be administered intravenously for amlodipine overdose to reverse calcium channel blockade effects. Hemodialysis is not effective for removing amlodipine or valsartan.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • Lithium
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) - for amlodipine component
  • NSAIDs (including COX-2 inhibitors) - risk of renal impairment and reduced antihypertensive effect
🟡

Moderate Interactions

  • CYP3A4 inducers (e.g., rifampin, St. John's Wort, carbamazepine, phenobarbital, phenytoin) - for amlodipine component
  • Grapefruit juice - for amlodipine component
  • Other antihypertensives (additive hypotensive effect)
  • Colesevelam (may reduce valsartan absorption)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide initial dosing.

Timing: Prior to initiation

Serum Potassium (K+)

Rationale: Valsartan can cause hyperkalemia, especially in patients with renal impairment or those on potassium-sparing diuretics.

Timing: Prior to initiation

Renal Function (SCr, BUN)

Rationale: Valsartan can cause acute renal failure, especially in patients with pre-existing renal impairment or bilateral renal artery stenosis.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: Amlodipine is extensively metabolized by the liver; valsartan exposure is increased in hepatic impairment.

Timing: Prior to initiation (especially if hepatic impairment suspected)

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly after dose changes, then monthly or every 3-6 months once stable

Target: <130/80 mmHg (individualized based on guidelines and patient comorbidities)

Action Threshold: Persistently elevated BP despite maximum dose, or symptomatic hypotension

Serum Potassium (K+)

Frequency: Periodically, especially after dose changes, or if co-administered with potassium-sparing agents or in renal impairment (e.g., 1-2 weeks after initiation/change, then every 3-6 months)

Target: 3.5-5.0 mEq/L

Action Threshold: >5.5 mEq/L or symptomatic hyperkalemia

Renal Function (SCr, BUN)

Frequency: Periodically, especially after dose changes, or if co-administered with NSAIDs/diuretics, or in renal impairment (e.g., 1-2 weeks after initiation/change, then every 3-6 months)

Target: Stable within patient's baseline range

Action Threshold: Significant increase in SCr (>30% from baseline) or signs of acute kidney injury

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fainting (signs of hypotension)
  • Swelling of face, lips, tongue, throat (angioedema)
  • Difficulty breathing
  • Chest pain
  • Palpitations
  • Peripheral edema (amlodipine-related)
  • Unusual fatigue or weakness
  • Signs of hyperkalemia (e.g., muscle weakness, irregular heartbeat)

Special Patient Groups

🤰

Pregnancy

Contraindicated during pregnancy due to the risk of fetal injury and death associated with the valsartan component (ARB). Discontinue as soon as pregnancy is detected.

Trimester-Specific Risks:

First Trimester: Limited data, but risk cannot be excluded. Category C.
Second Trimester: Significant risk of fetal injury (hypotension, oligohydramnios, anuria, renal failure, skull hypoplasia, lung hypoplasia, skeletal deformations, death). Category D.
Third Trimester: Significant risk of fetal injury (hypotension, oligohydramnios, anuria, renal failure, skull hypoplasia, lung hypoplasia, skeletal deformations, death). Category D.
🤱

Lactation

Use with caution. Amlodipine is present in human milk. It is unknown if valsartan is excreted in human milk, but it is present in rat milk. Due to the potential for adverse effects on the breastfed infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk). Monitor infant for hypotension, lethargy, and poor feeding.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in efficacy or safety were observed between elderly (â‰Ĩ65 years) and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Consider lower initial doses of the amlodipine component (e.g., 2.5 mg) if appropriate, and monitor closely for adverse effects, especially hypotension and peripheral edema.

Clinical Information

💎

Clinical Pearls

  • This combination is useful for patients whose blood pressure is not adequately controlled with either amlodipine or valsartan alone.
  • Peripheral edema, a common side effect of amlodipine, may be less pronounced when combined with valsartan due to the vasodilatory effects of valsartan.
  • Always check for pregnancy status in women of childbearing potential due to the Black Box Warning for fetal toxicity.
  • Monitor potassium levels, especially in patients with renal impairment, diabetes, or those on potassium-sparing diuretics/supplements.
  • Advise patients to report any signs of angioedema immediately, as this is a rare but serious side effect of ARBs.
🔄

Alternative Therapies

  • Other ARBs (e.g., losartan, irbesartan, candesartan)
  • Other CCBs (e.g., nifedipine, diltiazem, verapamil)
  • ACE inhibitors (e.g., lisinopril, enalapril)
  • Thiazide diuretics (e.g., hydrochlorothiazide)
  • Beta-blockers (e.g., metoprolol, carvedilol)
💰

Cost & Coverage

Average Cost: $30 - $200 per 30 tablets (generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about your medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.